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Summary
Objective: To identify pre-treatment predictors of who will beneﬁt from a 3e4-week comprehensive rehabilitation intervention in patients with
osteoarthritis (OA) of the knee or hip.
Methods: A prospective cohort study with assessments at admission to the clinic and after 6 months was conducted. Two hundred and ﬁfty
patients from the rehabilitation clinic Rehaclinic Zurzach, Switzerland, were included. Three different measures of response to a 3e4-week
comprehensive rehabilitation intervention were used: one indirect measure (minimal clinically important difference (MCID) in the Western On-
tario and McMaster Universities Osteoarthritis Index (WOMAC) global score¼ 18% improvement), one direct measure (transition question)
and a combination of both criteria. Responders were predicted by a sequential logistic regression analysis with nine personal variables,
ﬁve lifestyle risk factors, seven psychological status variables and the WOMAC global baseline score.
Results: The set of statistically signiﬁcant predictors was dependent on the deﬁnition of response. The comparison of predictors that were
statistically signiﬁcant in any of the prediction models showed similar odds ratios (ORs) for the majority of predictors across three regression
models with the different response deﬁnitions as dependent variable. Female gender, absence of depressive symptoms (dep), history of com-
plementary medicine (cm) and low comorbidity (com) were the most stable predictors and had ORs above 2.0 (female) and above 1.5 (dep,
cm, com) across the three regression models with different response deﬁnitions.
Conclusion: A set of predictors for the outcome of rehabilitation in patients with OA was identiﬁed. If these predictors could be conﬁrmed in
future research, this knowledge might help to adopt and individualize the treatment of patients who are, at present, less likely to respond.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Key words: Osteoarthritis, Rehabilitation, Outcome assessment, Regression Analysis, Predictor, WOMAC.
International
Cartilage
Repair
SocietyIntroduction
Osteoarthritis (OA) is a very disabling disease. The Global
Burden of Disease study developed a single measure to al-
low comparison of the burden of disease across many dif-
ferent disease conditions by including both death and
disability1. This measure has been called ‘‘Disability Ad-
justed Life Years’’ (DALYs). In this Global Burden of Dis-
ease study OA was one of the ﬁve most disabling
diseases and had a remarkable public health impact of
4.7 106 DALYs in the developed countries in 19901. The
prevalence of OA has been assessed at 12% in the Amer-
ican population2. Because of its high prevalence in the in-
creasing population of elderly people, an increase of
0.9 106 DALYs (19%) from 4.7 106 DALYs in 1990 up
to 5.6 106 DALYs in 2030 is estimated under the present
conditions3. Direct and indirect costs for OA of the hip and
knee in America were $12.9 billion in 19944.
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the guidelines of the American College of Rheumatology7,8
recommend that OA is treated with analgesics (parace-
tamol, opioids), non-steroidal anti-inﬂammatory drugs
(NSAIDs)9,10, exercise therapy11e13, patient education14,
and ﬁnally joint arthroplasty15,16.
Comprehensive multidisciplinary rehabilitation programs,
in Europe mostly in in-patient settings, combine these treat-
ment options (except arthroplasty). A previous study
showed that a signiﬁcant improvement achieved by partici-
pation in a multidisciplinary rehabilitation program may last
for 6 months17. However, in clinical experience the individ-
ual response to such rehabilitation programs varies consid-
erably. There has been no formal evaluation of predictors
for the outcome of rehabilitation programs in patients with
OA of the hip or knee, except one study that included
only patients after surgery of the hip or knee18. Knowledge
of predictors and the identiﬁcation of patients for whom the
probability of treatment success is low at the time of assess-
ment might facilitate the optimization of individually tailored
rehabilitation programs.
Therefore, the objective of this study was to identify pre-
treatment predictors of who will beneﬁt from a 3e4-week
comprehensive rehabilitation intervention in patients with
OA of the knee or hip.1
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predictors on the change of health status between entry
into the clinic and the 6-month follow-up. The secondary
aim was to evaluate whether the predictors were dependent
on the choice of the response criterion.
Methods
STUDY DESIGN
An observational prospective cohort study with assess-
ments at baseline (admission to the clinic) and 6 months af-
ter baseline was conducted. A follow-up period of 6 months
was chosen, because a previous study showed that a signif-
icant effect as measured by the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC)
global score may last for 6 months17.
SETTING
Patients who were referred to the Rehaclinic Zurzach,
Switzerland, by their family physician or rheumatologist
with the diagnosis of hip or knee OA so that they could par-
ticipate in a comprehensive rehabilitation intervention were
recruited to the study.
PATIENTS
Of 264 patients consecutively referred from March 1997
to January 2003, 250 patients with complete data sets could
be analyzed. All patients fulﬁlled the American College of
Rheumatology (ACR) criteria for diagnosis of OA19,20. Inclu-
sion criteria for knee OA were (1) knee pain for more than
25 of the last 30 days, (2) morning stiffness for less than
30 min, and (3) crepitation in the knee or: (1) knee pain
for more than 25 of the last 30 days and (2) osteophytes vis-
ible on the radiographs of the knees. Hip OA patients were
included when there was (1) hip pain for more than 25 of the
last 30 days and (2) at least two of the following three crite-
ria: (2.1) erythrocyte sedimentation rate <20 mm/h, (2.2)
osteophytes visible on the radiographs, or (2.3) obliteration
of the joint space.
INTERVENTION
The intervention was a comprehensive rehabilitation inter-
vention of 3e4 weeks duration. The individual treatment pro-
grams included exercise therapy, manual therapy, medical
massagetherapy,electrotherapy,hydrotherapy, thermotherapy,
instructions in coping techniques such as relaxation strate-
gies and distraction techniques, and patient education. The
details of the intervention have been described elsewhere17.
MEASURES
WOMAC (main outcome measure)21e23
The WOMAC is a condition-speciﬁc instrument, i.e., OA-
speciﬁc multidimensional measure of pain (ﬁve items), stiff-
ness (two items) and physical functional ability (17 items).
All 24 WOMAC items are rated on a numerical rating scale
ranging from 0 (‘‘no symptoms/no limitation’’) to 10 (‘‘maxi-
mal symptoms/maximal limitation’’), which is the format
used in the German validation study24. Similar to the Visual
Analogue Scale (VAS), this rating provides interval type
data. To score each scale the mean of the item scales iscalculated. For the calculation of the WOMAC global score
we weighted the different scales according to the differential
scale length in accordance to the WOMAC User’s Guide23:
Global¼ (5 painþ 2 stiffnessþ 17 function)/24. This
approach gives the highest weight to physical function
which is the main target of rehabilitation.
Transition scale
The so-called transition scale investigates the current
state of health of the OA joint at the 6-month follow-up com-
pared to its state 6 months earlier (at baseline examination).
Here is an example of this question for patients with OA of
the left hip: ‘‘Please imagine how you would have described
your health status six months ago. How do you feel in gen-
eral today as compared to six months earlier as far as your
osteoarthritis of the left hip is concerned?’’ The response
options were ‘‘much worse’’, ‘‘slightly worse’’, ‘‘equal’’,
’’slightly better’’ or ‘‘much better’’.
Self-administered Comorbidity Questionnaire
(SCQ)25
The SCQ asks the question ‘‘Do you have any of the fol-
lowing problems?’’ in relation to heart disease, high blood
pressure, lung disease, diabetes, ulcer or stomach disease,
kidney disease, liver disease, anemia or other blood dis-
ease, cancer, depression, arthritis and back pain. For
each problem the following optional questions are included
in the questionnaire: ‘‘Do you receive treatment for it?’’ and
‘‘Does it limit your activities?’’ as proxies for disease sever-
ity and the burden of disease. Arthritis as the cohort deﬁning
disease was excluded from the comorbidities.
Hospital Anxiety and Depression Scale (HADS)
The HADS covers two scales with seven items each to
measure anxiety and depression26. The scores have
a range from 0 to 21 (items: 0¼ best to 3¼worst). Patients
with a score between 0 and 7 are non-cases with healthy
mood, patients with a score of 8e10 are doubtful cases
and patients with a score of 11e21 are deﬁnite cases with
manifest anxiety or depression.
Sense of Coherence Scale (SOC)27
The ‘‘sense of coherence’’ of the patient is associated
with the patient’s salutogenically oriented way of life and be-
havior and is dependent on his or her ability to cope with
stress factors. The administered short form of this instru-
ment has 13 items. Answers are given on a seven-point
scale (1¼ best, 7¼worst).
Short Form 36 (SF-36)28
The SF-36 includes eight multi-item scales containing
2e10 items each plus a single item to assess health transi-
tion. The scales cover the dimensions of physical function-
ing, role physical, bodily pain, general health, vitality, social
functioning, role emotional and mental health. The ques-
tionnaire allows scoring of the eight scales mentioned
above and the compilation of two summary scales, namely,
the physical component summary scale and the mental
component summary scale. Since the dimensions of phys-
ical functioning were already covered by the WOMAC, in
this study only the four scales vitality, social functioning,
role emotional and mental health from the mental
643Osteoarthritis and Cartilage Vol. 14, No. 7component of the SF-36 were analyzed. The validated
German version was used29.
ANALYSES
Descriptive statistics, responsiveness,
definitions of responder
Descriptive statistics were calculated for baseline charac-
teristics. The statistical signiﬁcance of the change in WO-
MAC global score between baseline and the 6-month
follow-up was tested by paired t test. The effect size (ES)
was determined by dividing the change score between the
baseline and the 6-month follow-up by the standard devia-
tion (SD) of the baseline score30,31. Three different deﬁni-
tions of responder were used. The ﬁrst deﬁnition of
response was based on the concept of the minimal clinically
important difference (MCID)32. For the WOMAC global
score, a percentage change (100 (change of score/base-
line score)) greater or equal to 18% represents an MCID in
improvement. We used the percentage change as a mea-
sure of the difference in the health status and not the abso-
lute change because this method has been recommended in
situations with a high correlation between absolute change
and initial scores, and for health scales that deﬁne 0 to be
the best possible score33,34. Both criteria were fulﬁlled in
this study. The MCID of 18% is close to other suggestions
for a clinically relevant improvement that were proposed by
Ehrich et al. for the WOMAC (15%)35, by Kosinski et al. for
several SF-36 scales and the Health Assessment Question-
naire (HAQ) (around 20% for most of the scales)36 and by
Redelmeier for the HAQ (21%)37.
The second deﬁnition of responder used the transition
scale. Patientswho reported a slightly or amuch better health
status on the transition scale were classiﬁed as responders.
The agreement between this response deﬁnition and the
response deﬁnition ‘‘18% (MCID) improvement in the
WOMAC’’ was displayed by a cross table. The signiﬁcance
of the association was analyzed by using the chi-square
test. The mean and distribution of the WOMAC global score
at baseline and of the changes of the WOMAC global score
were compared between those who felt they had noted im-
provement and those who felt that they had no improvement.
Signiﬁcance of mean differences was tested by t tests.
The third deﬁnition of responder was a more restricted
deﬁnition and required that responders showed an MCID
in improvement on the WOMAC global score and reported
a health improvement on the transition scale.
Independent variables
Independent variables were classiﬁed into three cate-
gories. The ﬁrst category had nine variables, was labeled
‘‘Personal’’ and included sociodemographic variables, co-
morbidities and previous treatments with physiotherapy or
complementary medicine. The second category included
ﬁve variables that describe ‘‘Lifestyle Risk Factors’’ of the
patients. The third category consisted of variables related
to the ‘‘Psychological Status’’ of the patients. Potential pre-
dictors were analyzed for missing values. Cases with incal-
culable scores according to scoring algorithms, or missing
values on single measures, were excluded. Continuous var-
iables were dichotomized if a clinical meaningful cut-off
point was reported in the literature. For categorical variables
composed of more than two categories, the categories were
combined to form main categories taking into account the
number of cases per category and the clinical aspects ofeach category. For example, from the clinical perspective
a dichotomization of the SCQ into ‘‘no comorbidity’’ and
‘‘one or more comorbidities’’ seemed reasonable. Based
on the number of cases in one category we decided to com-
bine patients with no and with one comorbidity, because
only 8.8% of the patients had no comorbidity.
To examine whether disease severity is a predictor for re-
sponse the WOMAC global baseline score was included in
the analysis with the dependent variable ‘‘responder on the
transition scale’’. It was not included in the analysis with the
dependent variable ‘‘18% (MCID) improvement in the WO-
MAC’’, because this response deﬁnition was derived from
the relative change that adjusts for the expected high corre-
lation between absolute change and initial scores. Likewise,
the WOMAC baseline score was not included in the analy-
sis with the dependent variable ‘‘18% improvement (MCID)
in the WOMAC and responder on the transition scale’’.
The independent variables were:
Personal. The personal variable age was dichotomized
into younger than 63 years or 63 years, according to
the age of retirement in Switzerland (<63 years vs 63
years). The other personal variables were sex (female
vs male), study joint (hip vs knee), marital status (living
with a partner vs living alone), education (high school
graduate vs lower than high school graduate), insurance
status (national insurance vs private insurance), comor-
bidities (0e1 comorbidity vs >1 comorbidity), physiother-
apy (PT) in the last 12 months before rehabilitation
(‘‘had PT’’ vs ‘‘no PT’’) and history of complementary
medicine (cm) in the last 12 months before rehabilitation
(‘‘had cm’’ vs ‘‘had no cm’’).
Lifestyle Risk Factors. Smoking (yes vs no), alcohol
consumption (no, sometimes or one or more drinks daily),
sport (yes vs no), physical activity (more than 30 min/day
vs less or equal to 30 min/day) and diet (following a diet vs
no diet) were the ﬁve lifestyle risk factors.
Psychological Status. Depressive symptoms were mea-
sured by the HADS depression scale (HADS depression
score <8 vs HADS 8), anxiety was measured by the
HADS anxiety scale (HADS anxiety score <8 vs HADS 8)
and senseof coherencewasmeasuredby theSOC (contin-
uous). Vitality (continuous), social functioning (continuous),
role emotional (continuous) andmental health (continuous)
were measured by the corresponding scales of the SF-36.
Multivariate regression. Three logistic regression models
with different deﬁnitions of the dependent variable re-
sponder were developed. The selection of predictors
was performed in four steps. First, each independent vari-
able was subjected to initial screening of its relationship
with the dependent variable. Univariate chi-square tests
were used to analyze the associations between response
and binary independent variables, and the a-level was set
at 0.20 to ensure that potential predictors were not ex-
cluded at this stage. For continuous variables chi-square
tests for trend were calculated to assess the association
between response and these variables, the a-level was
again set at 0.20.
In the second step, logistic regression models were cal-
culated for the categories Personal, Lifestyle Risk Factors
and Psychological Status. Again, an a-level of 0.20 was
set for further consideration. In addition, to select the best
predictors in each category a backwards selection tech-
nique using the Likelihood Ratio Statistic with P< 0.05 to
stay in the model was used. All variables were screened
for collinearity by calculating bivariate spearmen correlation
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than 0.30 were not used together in the regression models.
In the third step, the selected variables from each cate-
gory were combined in one logistic regression model. The
best prediction model was developed by a backwards se-
lection technique using the Likelihood Ratio Statistic with
P< 0.05 to stay in the model.
In the fourth and last step, variables with P-values <0.20
in the univariate analysis, or variables that were statistically
signiﬁcant predictors in one of the other models, were
added one after the other to the model and stayed in the
model if the area under the receiver operating curve
(AUC) increased by 5%, or if the variable was a statistically
signiﬁcant predictor. Odds ratios (ORs) were calculated for
the ﬁnal predictors. Sensitivity and speciﬁcity were calcu-
lated to measure the ability of the models to discriminate be-
tween a responder and a non-responder. Two cut-off points
for the estimated probability of responder were chosen such
that for cut-off point 1 sensitivity was close to 80% and for
cut-off point 2 the speciﬁcity was close to 80%. The AUC,
sensitivity and speciﬁcity, and the number of correctly clas-
siﬁed patients for both cut-off points were used to compare
the regression models with different responder deﬁnitions.
To allow a comparison between the predictors of the dif-
ferent prediction models, additional models with all vari-
ables that were included in any of the prediction models
were calculated.
Interactions were analyzed by forming interaction terms
and testing their signiﬁcance. These analyses were per-
formed in the three regressionmodels that combined the pre-
dictors that were statistically signiﬁcantly associated with any
of the response deﬁnitions. Only the interactions between the
two predictors with the lowest P-values in each of the model
and the other variables were analyzed. If an interaction was
found in one of the three models, it was tested if this interac-
tion could be conﬁrmed in the other two models.
All statistical analyses were performed using the statisti-
cal software package SPSS 12.0 for Windows (SPSS
Inc., Chicago, IL, USA).
Results
PATIENTS AND OUTCOME
The baseline characteristics for 250 patients are shown in
Table I. The mean age was 65.3 years (SD: 10.0). The ma-
jority was female (72.0%). Thirty percent had less than two
comorbidities. The mean WOMAC global score improved
signiﬁcantly (P< 0.05) from 4.69 (SD: 2.07) before treat-
ment to 4.39 (SD: 2.27) at the 6-month follow-up. The ES
was 0.15. 34.4% of patients showed a clinically signiﬁcant
improvement in the WOMAC global score (18% change)
and 26.4% answered the transition question by stating
that their health was slightly or much better.
The agreement between improvement in one deﬁnition
and the other was statistically signiﬁcant (P< 0.001) and
is displayed in Table II. The mean of the WOMAC global
score at baseline was 4.52 (SD: 2.02) for responders
according to the transition question and did not differ signif-
icantly (P¼ 0.46) from the mean 4.75 (SD:2.01) of non-
responders. Those who were responders by the transition
question had an improvement of 1.32 in the WOMAC global
score. In contrast, the non-responders had a worsening of
0.06 in the WOMAC global score (P< 0.001).
Sixteen percent of the patients showed a clinically signif-
icant improvement in the WOMAC score and on the transi-
tion scale.PREDICTORS
Univariate analysis
The results of the univariate analysis of the associations
between the response criteria and the independent vari-
ables are displayed in Table III. Absence of depressive
symptoms (HADS depression score <8 vs 8) and history
of complementary medicine (had cm vs no cm) showed
statistically signiﬁcant associations to response indepen-
dently from the response deﬁnition and had ORs above
2.0 in all analysis. The ORs for low comorbidity (0e1 comor-
bidity vs >1 comorbidity) and hip joint (hip vs knee) were
Table I
Characteristics of the study population (n¼ 250)
Characteristic
WOMAC global baseline, mean (SD) 4.69 (2.07)
Personal characteristics
Age, mean (SD) 65.3 (10.0)
Age <63 years, N (%) 111 (44.4)
Female, N (%) 180 (72.0)
OA of hip joint, N (%) 89 (35.6)
Marital status (living with a partner), N (%) 170 (68.0)
High school graduates, N (%) 49 (19.6)
General health insurance, N (%) 141 (56.4)
Low number of comorbidities (0e1), N (%) 75 (30.0)
Physiotherapy in the last 12 months, N (%) 108 (43.2)
Complementary medicine in the last
12 months, N (%)
50 (20.0)
Lifestyle risk factors
Smokers, N (%) 33 (13.2)
Alcohol consumption: no, N (%) 92 (36.8)
Alcohol consumption: sometimes, N (%) 125 (50.0)
Alcohol consumption: one or more drinks/day,
N (%)
30 (12.0)
Physical activity >30 min/day, N (%) 135 (54.0)
Following a diet, N (%) 54 (21.6)
Psychological characteristics, N (%)
HADS depression score, mean (SD) 5.75 (3.45)
Absence of depressive symptoms (HADS
depression score <8), N (%)
181 (72.4)
HADS anxiety score, mean (SD) 6.92 (3.88)
Absence of anxiety (HADS anxiety score <8),
N (%)
137 (54.8)
SOC-score, mean (SD) 4.96 (0.95)
SF-36 vitality, mean (SD) 42.37 (20.08)
SF-36 social functioning, mean (SD) 65.15 (27.92)
SF-36 role emotional, mean (SD) 51.72 (44.53)
SF-36 mental health, mean (SD) 62.86 (20.03)
Table II
Agreement between responders with different definitions of
response
Responder 18% improvementy Total
Yes No
Responder
transition*
Yes 40 26 66
No 46 138 184
Total 86 164 250
The chi-square test showed a signiﬁcant association between the
two different deﬁnitions of response (P< 0.001).
*Patients who answered ‘‘slightly better’’ or ‘‘much better’’ to the
health transition question.
yPatients with an MCID on the WOMAC global score (18%
improvement).
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Predictors of response to rehabilitation on the univariate level
Independent variable 18% Improvementy Transitionz Both criteria
OR P-value OR P-value OR P-value
WOMAC global baseline na{ na{ 0.95 0.434 na{ na{
Personal
Age (63 years vs >63 years) 1.63 0.069 1.36 0.287 1.88 0.072
Sex (female vs male) 1.32 0.362 1.63 0.155 2.48 0.052
Study joint (hip vs knee) 1.51 0.135 1.77 0.053 1.60 0.178
Marital status (with partner vs living alone) 1.74 0.064 1.23 0.515 2.09 0.081
Education (high school graduate vs less than
high school graduate)
1.94 0.041 1.30 0.456 1.72 0.173
Insurance (national vs private) 2.37 0.002 0.90 0.723 1.75 0.126
Low comorbidity (1 vs >1) 1.54 0.132 1.96 0.025 2.49 0.010
Physiotherapy (had PT vs no PT) 1.23 0.444 0.96 0.882 1.39 0.345
Complementary medicine* (had cm vs no cm) 2.06 0.025 2.00 0.040 2.25 0.034
Lifestyle risk factors
Smoking (yes vs no) 0.81 0.595 1.05 0.903 0.93 0.887
Alcohol (sometimes vs no) 1.27 0.419 0.93 0.829 1.30 0.493
Alcohol (one drink/day vs no) 1.09 0.853 1.42 0.443 1.22 0.734
Sport (yes vs no) 1.57 0.094 1.45 0.200 2.00 0.053
Physical activity (>30 min/day vs 30 min/day) 1.49 0.138 1.44 0.211 1.52 0.241
Diet (yes vs no) 1.42 0.269 2.14 0.020 2.29 0.027
Psychological
No depressive symptoms (HADS dep <8 vs 8) 2.09 0.023 2.30 0.023 3.07 0.025
No anxiety (HADS anxiety <8 vs 8) 1.65 0.067 1.38 0.270 1.46 0.287
SOC 1.18 0.244 1.02 0.876 1.15 0.470
Vitality 1.01 0.108 1.01 0.190 1.00 0.998
Social functioning 1.00 0.908 1.00 0.750 1.00 0.940
Role emotional 1.00 0.803 1.00 0.794 1.00 0.690
Mental health 1.00 0.567 1.00 0.936 1.00 0.740
*Patients who had complementary medicine interventions in the last 12 months.
yPatients with an MCID on the WOMAC global score (18% change).
zPatients who answered ‘‘slightly better’’ or ‘‘much better’’ to the health transition question.
{Univariate analysis for the association between ‘‘WOMAC baseline score’’ and the response deﬁnitions ‘‘18% improvement in the WO-
MAC’’ and ‘‘both criteria’’, respectively, are not represented, because these response deﬁnitions adjust for the expected high correlation of
WOMAC baseline score and the change of the WOMAC.above 1.5 for all three response deﬁnitions, and sport (yes
vs no) had ORs between 1.45 and 2.00. The ORs for the
other independent variables were lower or showed more
varying results.
Multivariate analysis
Responder definition: 18% (MCID) improvement in the
WOMAC.
Personal. Statistically signiﬁcant predictors for a better
outcome were insurance status (OR 2.64, P¼ 0.001,
national vs private insurance), sex (OR 2.05, P¼ 0.032,
female vs male), marital status (OR 1.95, P¼ 0.036, living
with a partner vs living alone) and high education (OR
2.02, P¼ 0.037, high school graduate vs lower than
high school graduate).
Lifestyle Risk Factors. In this category the variable ‘‘sport’’
showed the highest OR (1.57, P¼ 0.094, sport before re-
habilitation vs no sport), but no lifestyle risk factor was
a statistically signiﬁcant predictor.
Psychological Status. In this category absence of depres-
sive symptoms (HADS depression score <8 vs 8) was
the only statistically signiﬁcant predictor for improvement
(OR 2.09, P¼ 0.023).
Categories combined. The most predictive regression
model is shown in Table IV. After combining theselected variables from the categories ‘‘Personal’’, ’’Life-
style Risk Factors’’ and ‘‘Psychological Status’’, insur-
ance status (national vs private insurance), history of
complementary medicine (had cm vs no cm) and
absence of depressive symptoms (HADS depression
score <8 vs 8) remained statistically signiﬁcant
predictors.
Responder definition: improvement on the transition scale
WOMAC global baseline score. The WOMAC global
baseline score showed no association to response
(P¼ 0.435).
Personal. Statistically signiﬁcant predictors for a better
outcome were low comorbidity (OR 2.63, P¼ 0.004,
0e1 comorbidity vs >1 comorbidity), sex (OR 2.41, P¼
0.020, female vs male) and joint (OR 1.91, P¼ 0.037,
hip vs knee). Patients with a history of complementary
medicine had an almost statistically signiﬁcant better
outcome (OR 1.96, P¼ 0.055, had cm vs no cm).
Lifestyle Risk Factor. In this category diet was the only
statistically signiﬁcant predictor (OR 2.14, P¼ 0.020, fol-
lowing a diet before rehabilitation yes vs no).
Psychological Status. Absence of depressive symptoms
was the only statistically signiﬁcant predictor for improve-
ment in this category (OR 2.30, P¼ 0.023, HADS depres-
sion score <8 vs 8).
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Comparison of prediction models for OA rehabilitation with different definitions of responder
Responder deﬁnition Responder,
N (%)
AUC Predictors b-Coefﬁcient P-value OR 95% CI
18% Improvement* 86 (34.4) 0.65
Constant 1.779
Insurance (national vs private) 0.807 0.005 2.24 1.28e3.94
Complementary medicine (had
cm vs no cm)z
0.712 0.032 2.04 1.06e3.91
No depressive symptoms (HADS
dep <8 vs 8)
0.664 0.045 1.94 1.01e3.72
Transitiony 66 (26.4) 0.66
Constant 2.438
Low comorbidity (0e1 vs >1) 1.038 0.002 2.82 1.46e5.48
Diet (yes vs no) 0.819 0.019 2.27 1.15e4.50
Sex (female vs male) 0.823 0.031 2.28 1.08e4.82
Joint (hip vs knee) 0.662 0.033 1.94 1.05e3.56
Both criteria 40 (16.0) 0.72
Constant 4.444
Low comorbidity (0e1 vs >1) 1.491 <0.001 4.44 1.99e9.93
Sex (female vs male) 1.562 0.003 4.77 1.69e13.46
Marital status (with partner vs
living alone)
1.067 0.017 2.91 1.21e7.00
Diet (yes vs no) 0.948 0.023 2.58 1.14e5.83
*Patients with an MCID on the WOMAC global score (18% change).
yPatients who answered ‘‘slightly better’’ or ‘‘much better’’ to the health transition question.
zPatients who had complementary medicine interventions in the last 12 months.Categories combined. The best prediction model is shown
in Table IV. It included the variables sex (female vs male),
joint (hip vs knee) and comorbidity (0e1 comorbidity vs>1
comorbidity) from the category Personal and diet (following
a diet vs no diet) from the category Lifestyle Risk Factors.
Responder definition: 18% improvement in the WOMAC
and improvement on the transition scale.
Personal. Statistically signiﬁcant predictors for a better
outcome were low comorbidity (OR 4.19, P< 0.001,
0e1 comorbidity vs >1 comorbidity), sex (OR 5.04,
P¼ 0.002, female vs male) and marital status (OR 2.75,
P¼ 0.025, with partner vs living alone). A history of com-
plementary medicine was an almost signiﬁcant predictor
(OR 2.23, P¼ 0.052, had cm vs no cm).
Lifestyle Risk Factor. In this category diet was a statisti-
cally signiﬁcant predictor (OR 2.30, P¼ 0.028, following
a diet before rehabilitation yes vs no) and sport (OR
2.02, P¼ 0.053, sport before rehabilitation vs no sport)
was an almost statistically signiﬁcant predictor.
Psychological Status. In this category absence of depres-
sive symptoms was the only statistically signiﬁcant predic-
tor for improvement (OR 3.07, P¼ 0.025, HADS
depression score <8 vs 8).
Categories combined. The best prediction model is shown
in Table IV. After combining the selected variables from
the three categories and using the backwards selection
procedure, sex (female vs male), low comorbidity (0e1
comorbidity vs >1 comorbidity), marital status (with part-
ner vs living alone) and diet (following a diet vs no diet)
were statistically signiﬁcant predictors.
COMPARISON OF PREDICTION MODELS WITH DIFFERENT
RESPONDER DEFINITIONS
Table IV compares the prediction models with different
deﬁnitions of responder. No variable was included in allthree ﬁnal regression models. The model with the most re-
strictive responder deﬁnition that required responders to
have an 18% improvement in the WOMAC score and an im-
provement on the transitions scale had the highest value for
the AUC (AUC¼ 0.72). This model also showed the highest
number of correctly classiﬁed patients for cut-off point 2 that
was chosen such that speciﬁcity is close to 80%, but not for
cut-off point 1 that was chosen such that sensitivity is close
to 80% (Table V).
COMPARISON OF THE CHARACTERISTICS OF PREDICTORS
IN DEPENDENCY ON THE DEFINITION OF RESPONSE
Table VI compares the characteristics of predictors in de-
pendency on the deﬁnition of response. All variables, with
the exception of insurance status, had OR above 1 in the
regression models with different response deﬁnition. The
ORs for sex (female vs male) were above 2.1 in all models.
Absence of depressive symptoms (HADS <8 vs HADS 8),
complementary medicine (yes vs no) and comorbidity (0e1
comorbidity vs >1 comorbidity) had ORs above 1.5 in all
models. Joint (hip vs knee) and diet (yes) had low ORs in
the models with the response deﬁnition ‘‘18% improvement’’
(joint OR 1.38, diet OR 1.15), but substantially higher OR in
the two other models (model transition: joint OR 1.91, diet
OR 1.95, model both criteria: joint OR 1.61, diet OR 2.03).
The results were conﬂicting for insurance status (national
vs private) with an OR of 2.28 for the model ‘‘18% improve-
ment’’, 0.71 for the model ‘‘transition’’ and 1.54 for the
model ‘‘both criteria’’.
INTERACTIONS
In the regression model with the dependent variable
‘‘18% improvement’’ a signiﬁcant interaction was found be-
tween insurance status and absence of depression
(P¼ 0.012 for the interaction term). Stratiﬁed analysis
showed that in the group of patients with absence of
depressive symptoms the insurance status was not a
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Classification tables for two different cut-off points of the estimated probability of responder
Model Correctly classiﬁed Incorrectly classiﬁed Correct (%) Sensitivity (%) Speciﬁcity (%)
Responders (n) Non-responders (n) Responders (n) Non-responders (n)
18% Improvement*
Cut-off 1 69 72 92 17 56.4 80.2 43.9
Cut-off 2 15 149 15 71 65.6 17.4 90.9
Transitiony
Cut-off 1 47 83 101 19 52.0 71.2 45.1
Cut-off 2 29 144 40 37 69.2 43.9 78.3
Both criteria
Cut-off 1 33 84 126 7 46.8 82.5 40.0
Cut-off 2 20 167 43 20 74.8 50.0 79.5
Two cut-off points for the estimated probability of responder were chosen such that for cut-off point 1 sensitivity was close to 80% and for
cut-off point 2 the speciﬁcity was close to 80%.
*Patients with an MCID on the WOMAC global score (18% improvement).
yPatients who answered ‘‘slightly better’’ or ‘‘much better’’ to the health transition question.statistically signiﬁcant predictor for a good outcome (OR
1.42, conﬁdence interval (CI) 0.73e2.75, P¼ 0.304, na-
tional vs private insurance), but this variable was a statisti-
cally highly signiﬁcant predictor in the group of patients with
depressive symptoms (OR 22.61, CI 3.55e144.16,
P¼ 0.01). In the regression model with the dependent vari-
able ‘‘transition scale’’ there was a signiﬁcant interaction be-
tween comorbidity and joint (P¼ 0.035). Comorbidity was
a statistically highly signiﬁcant predictor (OR 6.08, CI
1.92e19.20, P¼ 0.002, 0e1 comorbidity vs >1 comorbid-
ity) in patients with OA of the hip, but comorbidity was no
signiﬁcant predictor in patients with OA of the knee (OR
1.28, CI 0.54e3.06, P¼ 0.572).
Both interactions were not conﬁrmed in the regression
models with the other response deﬁnitions.
Discussion
In this prospective cohort study the pre-treatment predic-
tors for response to a comprehensive rehabilitation program
were identiﬁed. The response was measured by one direct
measure, the transition scale, one indirect measure, the
WOMAC global score and a combination of both response
measures. Absence of depressive symptoms, female gen-
der, a history of complementary medicine and low comor-
bidity were the most stable predictors because they were
conﬁrmed by similar ORs across three logistic regression
models with different deﬁnitions of response as dependent
variable.
Absence of depressive symptoms showed in the univari-
ate analysis statistically signiﬁcant associations to response
across all response deﬁnitions. In the logistic regression
model that compared the predictors in dependency on the
response deﬁnition the ORs for depressive symptoms
(HADS depression score <8 vs 8) ranged from 1.87 to
2.34. Although depression is a well-known predictor for
poor outcome and increased mortality in all health condi-
tions except malignant growths38, depressive symptoms
are often neglected in the rehabilitation of musculoskeletal
diseases. The lower response of depressed patients to
musculoskeletal rehabilitation may be mediated by a lack
of energy and drive and, as a consequence, by lower adher-
ence to home exercise programs. Screening of the emo-
tional status of the patients and individually tailored
psychological interventions could improve the beneﬁcial ef-
fects of rehabilitation.Female gender showed the highest ORs in the three re-
gression models that compared the predictors in depen-
dency on the response deﬁnition (OR from 2.11 to 5.16,
P-values 0.002e0.037, female vs male). Regarding sex,
previous studies showed conﬂicting results. Chen et al.
found no association between sex and functional gains after
rehabilitation in orthopedic patients39. Band et al. described
a better outcome for females with ankylosing spondylitis af-
ter in-patient rehabilitation40 and, in contrast, males were
found to have a better outcome in a study of patients with
OA who participated in in-patient rehabilitation programs af-
ter joint arthroplasty18. Some of the different results in these
studies may be explained by the heterogeneity of the stud-
ies. Predisposing factors may vary depending on the type of
interventions, the investigated health condition and charac-
teristics of the study population.
The association between ‘‘history of complementary
medicine’’ and response to rehabilitation was stronger
than expected. The credibility of this predictor is strength-
ened by the signiﬁcant univariate associations to response
across the three response deﬁnitions and by ORs between
1.69 and 1.86 in the models that compared the predictors in
dependency on the response deﬁnition. ‘‘History of comple-
mentary medicine’’ may be a proxy measure for the motiva-
tion of the patients to follow a healthy lifestyle, and that
again may result in a better outcome 6 months after rehabil-
itation. ‘‘History of complementary medicine’’ showed no
relevant correlations (r< 0.15) to any of the comorbidities
that were collected by the SCQ.
The better outcome for patients with less than two comor-
bidities is consistent with a study of patients after total hip
replacement with a follow-up of 3 years41. A high number
of comorbidities may restrict a patient’s ability to participate
in certain parts of the exercise program. For example,
patients with advanced coronary heart disease cannot
participate in exercise therapies that require a high cardio-
vascular capacity.
Patients who were living together with a partner had a bet-
ter outcome compared to patients living alone. This is in line
with the literature42,43 and may be mediated by a better ad-
herence to the patient education and the instructions for
home exercises44,45.
The predictor ‘‘following a diet’’ may be a proxy measure
for the motivation of the patients to follow a healthy lifestyle,
as suggested for the predictor ‘‘history of complementary
medicine’’. Diet showed a weak, statistically signiﬁcant cor-
relation to the comorbidities diabetes (r¼ 0.29, P< 0.001)
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.and obesity (r¼ 0.19, 0< 0.003) that were collected by the
SCQ. But this association cannot explain the better out-
come for patients following a diet, because patients with di-
abetes and obesity showed a worse outcome that was not
statistically signiﬁcant (OR 0.49, P¼ 0.211, diabetes vs no
diabetes; OR 0.73, P¼ 0.248, obesity vs no obesity).
It is not obvious why patients with a national insurance or
patients with hip OA have a better outcome. The OR for in-
surance status (national vs private insurance) was above
one in the regression model with the dependent variable
‘‘18% improvement in the WOMAC’’ (OR 2.28), but below
one for the model with the dependent variable ‘‘improve-
ment on the transition scale’’ (OR 0.71). This conﬂicting re-
sult weakens the credibility of this predictor.
Some other independent variables showed in the univar-
iate analysis statistically signiﬁcant associations to one of
the response deﬁnitions or consistently relevant ORs
across the three response deﬁnitions, but were removed
in the sequential selection of the best predictors. Education
was in the univariate analysis statistically signiﬁcantly asso-
ciated to the outcome ‘‘18% improvement (MCID) of the
WOMAC’’ (OR 1.94, P¼ 0.041, high school graduate vs
less than high school graduate). A better outcome for high
educated patients was also found in studies that evaluated
the outcome of joint arthroplasty46,47. In the comparison of
the outcome of patients younger than 63 years vs patients
older than 63 years the ORs ranged from 1.36 to 1.88 in
the univariate analysis. In the literature, a better outcome
for younger patients has been reported39,40.
The predictors were evaluated in only one study center in
Switzerland. Therefore, generalization to other populations
should be subject to caution. A large set of complete data
on sociodemographic variables, comorbidities, lifestyle
risk factors and psychological variables were entered into
the regression models, but no clinical measurements were
taken. Likewise, the body mass index was not taken rou-
tinely. Variables from clinical measures before treatment
may increase the ability to discriminate responder and
non-responder. However, if clinical variables or the body
mass indexes are associated with sociodemographic fac-
tors, these associations can mask associations between
sociodemographic factors and the outcome.
Another limitation of this study is the fact that no X-rays
were taken. Accordingly, it could not be analyzed whether
structural changes predict the outcome. The WOMAC
global score was used as indirect measure of symptomatic
severity. It was included in the analysis with the response
criterion ‘‘improvement on the transition scale’’, but it
showed no association to response. The WOMAC global
score was not included in the analysis with the dependent
variable ‘‘18% (MCID) improvement in the WOMAC’’, be-
cause this response deﬁnition adjusts for the expected
high correlation between absolute change and initial scores.
If there would be an association between WOMAC baseline
score and this response criterion, an unsuccessful adjust-
ment for the expected correlation between absolute change
and initial scores could not be distinguished from an asso-
ciation between symptom severity and response. Likewise,
the WOMAC baseline score was not included in the analy-
sis with the dependent variable ‘‘18% improvement in the
WOMAC and improvement on the transition scale’’.
In the interpretation of the predictors it should be consid-
ered that in a study design without control group it is not
possible to clearly distinguish predictors for the outcome
of rehabilitation from predictors for the natural course of
OA. The patients showed an improvement 6 months after
the rehabilitation, whereas in the natural history of OA,
649Osteoarthritis and Cartilage Vol. 14, No. 7a chronic progressive disease, deterioration would be ex-
pected, it is likely that the detected predictors are predomi-
nately predictors of the rehabilitation outcome and not of the
natural course.
In rehabilitation medicine there is no generally agreed-
upon deﬁnition of a responder. One of the simplest ways
to deﬁne a responder is to ask the patient about a health
transition, for example: ‘‘How do you feel in general today
as compared to three months earlier as far as your osteoar-
thritis of the left hip is concerned?’’ There are two main ad-
vantages of this method. First, it is simple and intuitive.
Second, patients with a very good and with a very bad
health status can improve or deteriorate. This is in contrast
to closed measurement scales where patients at the end of
the scale can change only in one direction. One drawback
of a single transition question is that it cannot be considered
a stable measure. It may be affected by short-term adverse
effects on the health status or by the actual mood of the pa-
tient. In addition, patients may not remember their initial
health status.
Another way to deﬁne a responder is to use a self-assess-
ment questionnaire like the WOMAC, and to deﬁne a cut-off
point for the change in the score that separates the re-
sponder from the non-responder. The concept of an
‘‘MCID’’ in improvement can be used to determine the cut-
off point32. The main advantage of this method is that health
status instruments like the WOMAC are reliable and valid
measures and more stable than a single transition question.
An important disadvantage is that patients with a score that is
far removed from the average of the population show a ‘‘re-
gression-to-the-mean-effect’’, a statistical phenomenon32,48.
This phenomenon especially affects the results when
‘‘closed’’ assessment scales like the WOMAC scales
(0¼ best, 10¼worst) are used because, at the extreme
ends of the scale, patients can only change in one direction.
Therefore, patients with baseline scores far above the
average (bad health) show higher improvements in the
change score compared to patients with a good health
status. As expected, this proved true in our results. The
percentage of responders increased from the ﬁrst to the third
tertile of theWOMAC baseline values from 18.8% to 44.6% if
an improvement of the WOMAC score of 0.82 (MCID) was
used to deﬁne a responder. In contrast, the response to
the transition question was not dependent on the WOMAC
baseline tertile.
In this study, we adjusted for the regression to the mean
effect by using the percentage change (100  (change of
score/baseline score)) instead of the change of score to de-
ﬁne responders. With a cut-off point at 18% (MCID), there
was only a slight increase in the percentage of responders
from the ﬁrst tertile of the WOMAC baseline scores (32.9%)
to the third tertile (44.6%). However, this adjustment also
has some problems. First, this adjustment does not work
for patients who are very close to the end of the scale. A pa-
tient with a score of 10 on the WOMAC score can only get
better, but not worse. Second, percentage change is not
a symmetric measure. Accordingly, the results would
change if the WOMAC were transformed into a scale where
high values indicated good health.
The third response deﬁnition in this study was a combina-
tion of the transition question and percentage change. A
misclassiﬁcation of responders was unlikely due to these
restrictive criteria. The highest AUC of all the three ﬁnal re-
gression models showed that this model had a better ability
to discriminate between responders and non-responders
than the other two models. However, the disadvantage of
this restrictive response deﬁnition is that a higher numberof misclassiﬁed non-responders is likely and that the total
number of responders may understate the effectiveness
of the intervention.
In this study, ORs are presented to compare the probabil-
ity of response between different groups of patients be-
cause ORs are closely related to logistic regression
analysis and they represent a well-known ordinal measure
to compare probabilities. In the interpretation of the ORs it
should be considered that response is no rare event and,
therefore, the ORs have higher values than the relative risks
and overstate the effects of the predictors49.
The results of the interaction tests suggest that if re-
sponders are deﬁned by ‘‘18% improvement in the WOMAC’’
insurance status is only a predictor in patients with depres-
sive symptoms. The second statistically signiﬁcant result of
the interaction test was that if the responders are deﬁned by
the transition scale comorbidity is a statistically signiﬁcant
predictor in patients with hip OA, but not in patients with
knee OA. However, the results of the interaction tests
should be interpreted with caution because these interac-
tions could not be conﬁrmed in regression models with
both other response deﬁnitions. Furthermore, the CIs
were very wide and due to the multiple interaction tests
one test could be statistically signiﬁcant by chance.
In conclusion, a set of predictors for the outcome of reha-
bilitation in patients with OA was identiﬁed. The depen-
dence of the statistical signiﬁcance of predictors on the
deﬁnition of responders showed that it is essential to stan-
dardize outcome measures and response criteria to allow
comparisons across different studies. The potential predic-
tors of this study should be considered in future research.
If predictors could be conﬁrmed, this knowledge might
help to adopt and individualize the treatment of patients
who are, at present, less likely to respond.
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